Skip to main content
. 2019 Nov 14;19(4):311–318. doi: 10.1007/s40268-019-00288-x

Fig. 1.

Fig. 1

PRISMA diagram detailing the study selection process. Identified papers describe dupilumab treatment of atopic dermatitis and dupilumab-associated conjunctivitis